These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 6335073)
21. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis. Kim KS; Anthony BF Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577 [TBL] [Abstract][Full Text] [Related]
22. Plasmid-mediated resistance to trimethoprim-sulfamethoxazole in Salmonella krefeld strains isolated in the United States. Mathewson JJ; Murray BE Antimicrob Agents Chemother; 1983 Mar; 23(3):495-6. PubMed ID: 6601930 [TBL] [Abstract][Full Text] [Related]
23. The isolation of thymidine-requiring Haemophilus influenzae from the sputum of chronic bronchitic patients receiving trimethoprim. Platt DJ; Guthrie AJ; Langan CE J Antimicrob Chemother; 1983 Mar; 11(3):281-6. PubMed ID: 6341348 [TBL] [Abstract][Full Text] [Related]
24. [The sulfamethoxazole-trimethoprim combination 1st survey into its in vitro activity in brazzaville, Congo Results of 780 bacterial strains isolated at the National Laboratory and the General Hospital in a single year]. Yala F Bull Soc Pathol Exot Filiales; 1979; 72(3):198-204. PubMed ID: 400121 [TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of trimethoprim/sulfadiazine and procaine penicillin G in a Streptococcus equi subsp. zooepidemicus infection model in ponies. Ensink JM; Smit JA; van Duijkeren E J Vet Pharmacol Ther; 2003 Aug; 26(4):247-52. PubMed ID: 12887605 [TBL] [Abstract][Full Text] [Related]
26. Trimethoprim resistance and single-agent use. Maskell R; Pead L Lancet; 1989 Sep; 2(8662):557-8. PubMed ID: 2570249 [No Abstract] [Full Text] [Related]
27. [The resistance of urinary tract bacteria in hospital environment over a 4-year period. A prospective study with special reference to trimethoprim, sulfonamide and a combination of them]. Busk HE; Korner B; Hammer R Ugeskr Laeger; 1985 Nov; 147(48):3895-7. PubMed ID: 3878615 [No Abstract] [Full Text] [Related]
28. In vitro susceptibilities of canine urinary bacteria to selected antimicrobial agents. Rohrich PJ; Ling GV; Ruby AL; Jang SS; Johnson DL J Am Vet Med Assoc; 1983 Oct; 183(8):863-7. PubMed ID: 6415021 [TBL] [Abstract][Full Text] [Related]
29. Kinetics and mechanisms of action of 'folate synthesis inhibitors', alone or in combination, on Escherichia coli. III. Pyrimethamine, trimethoprim and sulfamethoxazole. Seydel JK; Wempe E Chemotherapy; 1975; 21(3-4):131-45. PubMed ID: 1098865 [TBL] [Abstract][Full Text] [Related]
30. [Value of bead-type cassettes for antibiograms of Streptococci in Autobac units]. Viot M; Cambon P; Blondel P Pathol Biol (Paris); 1988 May; 36(5):398-402. PubMed ID: 3043336 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares. Brown MP; Gronwall R; Castro L Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143 [TBL] [Abstract][Full Text] [Related]
32. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin. Bailey RR; Peddie BA N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613 [No Abstract] [Full Text] [Related]
33. In vitro susceptibility of equine Salmonella strains to trimethoprim and sulfonamide alone or in combination. van Duijkeren E; van Klingeren B; Vulto AG; Sloet van Oldruitenborgh-Oosterbaan MM; Breukink HJ; van Miert AS Am J Vet Res; 1994 Oct; 55(10):1386-90. PubMed ID: 7998695 [TBL] [Abstract][Full Text] [Related]
34. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Brown PD; Freeman A; Foxman B Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of co-trimazine after single and multiple doses. Leone N; Barzaghi N; Monteleone M; Perucca E; Cerutti R; Crema A Arzneimittelforschung; 1987 Jan; 37(1):70-4. PubMed ID: 3566861 [TBL] [Abstract][Full Text] [Related]
36. Validating an empiric sulfadiazine-trimethoprim dosage regimen for treatment of Escherichia coli and Staphylococcus delphini infections in mink (Neovison vison). Ronaghinia AA; Nikolaisen NK; Hansen SG; Poulsen HH; Frandsen HL; Struve T; Toutain PL; Damborg P J Vet Pharmacol Ther; 2021 Jan; 44(1):93-106. PubMed ID: 32924166 [TBL] [Abstract][Full Text] [Related]
37. Serum and synovial fluid steady-state concentrations of trimethoprim and sulfadiazine in horses with experimentally induced infectious arthritis. Bertone AL; Jones RL; McIlwraith CW Am J Vet Res; 1988 Oct; 49(10):1681-7. PubMed ID: 3189982 [TBL] [Abstract][Full Text] [Related]
38. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. Murray BE; Rensimer ER; DuPont HL N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of Veterinary-Specific Interpretive Criteria for Susceptibility Testing of Streptococcus equi Subspecies with Trimethoprim-Sulfamethoxazole and Trimethoprim-Sulfadiazine. Sadaka C; Kanellos T; Guardabassi L; Boucher J; Watts JL J Clin Microbiol; 2017 Jan; 55(1):326-330. PubMed ID: 27847375 [TBL] [Abstract][Full Text] [Related]
40. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates. Obaseiki-Ebor EE Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]